340B covered entities may get more access to contrast media, radiopharmaceuticals at 340B prices soon. Consolidated Appropriations Act 2023 includes new law requiring FDA to treat all contrast media, radiopharmaceuticals, over-the-counter OTC monograph drugs as drugs.
The Food and Drug Administration let sponsors and requestors of over-the-counter (“OTC”) monograph drugs know how to be in the room where it happens when it issued a draft guidance this.